MDSO - Medidata Solutions, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
69.46
+1.35 (+1.98%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close68.11
Open68.47
Bid55.00 x 800
Ask69.61 x 800
Day's Range68.18 - 69.56
52 Week Range59.60 - 88.87
Volume724,221
Avg. Volume499,491
Market Cap4.251B
Beta (3Y Monthly)1.56
PE Ratio (TTM)81.81
EPS (TTM)0.85
Earnings DateFeb 6, 2019 - Feb 11, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est80.83
Trade prices are not sourced from all markets
  • Business Wire2 days ago

    Medidata Named Best Workplace in Technology by Great Place to Work® and FORTUNE

    Great Place to Work and FORTUNE named Medidata (MDSO) one of the 2019 Best Workplaces in Technology. The Best Workplaces in Technology provide excellent environments for all employees, regardless of position or other personal characteristics. Medidata employees (Medidatians) highly ranked the company’s atmosphere, rewards, and management transparency.

  • Markit3 days ago

    See what the IHS Markit Score report has to say about Medidata Solutions Inc.

    # Medidata Solutions Inc ### NASDAQ/NGS:MDSO View full report here! ## Summary * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate ## Bearish sentiment Short interest | Neutral Short interest is moderately high for MDSO with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $2.51 billion over the last one-month into ETFs that hold MDSO are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Negative According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Technology sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Frank Sands Courts Match Group, Dumps Medidata Solutions
    GuruFocus.com9 days ago

    Frank Sands Courts Match Group, Dumps Medidata Solutions

    Guru Frank Sands (Trades, Portfolio), CEO and chief investment officer of Sands Capital Management, revealed this week he added one new stock to his portfolio and divested of another on Dec. 31. Warning! GuruFocus has detected 1 Warning Sign with MTCH.

  • Medidata Solutions, Inc. (NASDAQ:MDSO) Insiders Have Been Selling
    Simply Wall St.10 days ago

    Medidata Solutions, Inc. (NASDAQ:MDSO) Insiders Have Been Selling

    We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples Read More...

  • Markit11 days ago

    See what the IHS Markit Score report has to say about Medidata Solutions Inc.

    # Medidata Solutions Inc ### NASDAQ/NGS:MDSO View full report here! ## Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate ## Bearish sentiment Short interest | Neutral Short interest is moderately high for MDSO with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Positive ETF activity is positive. Over the last month, ETFs holding MDSO are favorable, with net inflows of $4.92 billion. Additionally, the rate of inflows is increasing. ## Economic sentiment PMI by IHS Markit | Negative According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Technology sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Medidata Appoints Industry Leader Sastry Chilukuri as Executive Vice President of Digital and AI Solutions
    Business Wire13 days ago

    Medidata Appoints Industry Leader Sastry Chilukuri as Executive Vice President of Digital and AI Solutions

    Medidata  today announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its senior leadership team.

  • Business Wire24 days ago

    Medidata to Present at the 37th Annual J.P. Morgan Healthcare Conference

    Medidata today announced that Tarek Sherif, chairman and chief executive officer, and Rouven Bergmann, chief financial officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan.

  • How Do Analysts See Medidata Solutions, Inc. (NASDAQ:MDSO) Performing Over The Next Year?
    Simply Wall St.29 days ago

    How Do Analysts See Medidata Solutions, Inc. (NASDAQ:MDSO) Performing Over The Next Year?

    Looking at Medidata Solutions, Inc.'s (NASDAQ:MDSO) earnings update in September 2018, the consensus outlook from analysts appear somewhat bearish, with earnings expected to grow by 2.9% in the upcoming year Read More...

  • Hedge Funds Are Betting On Medidata Solutions Inc (MDSO)
    Insider Monkey29 days ago

    Hedge Funds Are Betting On Medidata Solutions Inc (MDSO)

    At Insider Monkey, we pore over the filings of more than 700 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we’ve gathered as a result gives us access to a wealth of collective knowledge based on these firms’ portfolio holdings as of September 30. In […]

  • Cala Health Picks Medidata Cloud for Observational Study
    Zackslast month

    Cala Health Picks Medidata Cloud for Observational Study

    Medidata's (MDSO) Cloud platform sees a slew of developments in recent times.

  • See what the IHS Markit Score report has to say about Medidata Solutions Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Medidata Solutions Inc.

    To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wirelast month

    Cala Health Streamlines Data and Operational Management for Neurological Device Study with Medidata Cloud

    Study leverages Medidata Rave EDC, Edge eTMF and Edge Payments

  • Business Wirelast month

    No Need for End of Study CDs: Medidata Introduces NEW Rave Digital EOS Media Delivery

    Sponsors, CROs, and Sites Retain and Easily Access End Of Study Media Necessary to Meet Regulatory Requirements

  • See what the IHS Markit Score report has to say about Medidata Solutions Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Medidata Solutions Inc.

    Medidata Solutions Inc NASDAQ/NGS:MDSO

  • GlobeNewswirelast month

    Detailed Research: Economic Perspectives on AT&T, JD, EMC Insurance Group, Insys Therapeutics, Medidata Solutions, and Heritage-Crystal Clean — What Drives Growth in Today's Competitive Landscape

    NEW YORK, Dec. 06, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Business Wire2 months ago

    Medidata Rave Omics Collaboration Uncovers Novel Insights for Rare Disease Research

    Discovery of biomarker evidence in Castleman Disease exemplifies the value of personalized medicine in rare diseases

  • Don’t Sell Medidata Solutions Inc (NASDAQ:MDSO) Before You Read This
    Simply Wall St.2 months ago

    Don’t Sell Medidata Solutions Inc (NASDAQ:MDSO) Before You Read This

    This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). We’ll look at Medidata Solutions Inc’s (NASDAQ:MDSO) P/E ratio and reflect Read More...

  • Medidata Rave Engage Wins Scrip Award for Best Sponsor-Focused Technological Development in Clinical Trials
    Business Wire2 months ago

    Medidata Rave Engage Wins Scrip Award for Best Sponsor-Focused Technological Development in Clinical Trials

    NEW YORK-- -- Rave Engage Named Top Technology for Sponsors at 14th Annual Scrip Awards Medidata Wins Prestigious Industry Award for Third Consecutive Year Scrip Award Celebrates Innovation and Excellence in Biopharmaceutical Industry Medidata is pleased to announce that Rave Engage was recognized at the 2018 Scrip Awards as the "Best Technological Development in Clinical Trials - Tech Sponsor ...

  • Business Wire2 months ago

    Federal Court Rejects Veeva’s Attack on Medidata’s Theft of Trade Secret Claims

    The United States District Court for the Southern District of New York has rejected Veeva’s motion to dismiss Medidata’s complaint against Veeva for theft of trade secrets, the company announced today. “The Court’s decision allows us to continue with our effort to hold Veeva accountable for its illegal and unethical misappropriation of Medidata’s valuable proprietary information and trade secrets,” said Erik Snider, senior director of corporate communications at Medidata.

  • Here's Why Investors Should Hold Medidata (MDSO) Stock Now
    Zacks2 months ago

    Here's Why Investors Should Hold Medidata (MDSO) Stock Now

    Solid prospects in the Rave Genomics platform are likely to provide Medidata (MDSO) a competitive edge in the MedTech space.

  • See what the IHS Markit Score report has to say about Medidata Solutions Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Medidata Solutions Inc.

    Medidata Solutions Inc NASDAQ/NGS:MDSO

  • Business Wire2 months ago

    Medidata to Present at Upcoming Investor Conferences

    Medidata today announced its participation in two upcoming investor conferences.

  • Business Wire2 months ago

    Two Research Studies Supported by Medidata to be Presented at ASH 2018

    NEW YORK-- -- Medidata Rave Omics Machine Learning Identifies New Evidence of Biomarkers in Rare Disease Research by the Castleman Disease Collaborative Network Memorial Sloan Kettering Cancer Center Monitors Newly Diagnosed Myeloma Patients with Medidata ePRO The Castleman Disease Collaborative Network will present results of a large-scale proteomics study of idiopathic multicentric Castleman disease ...

  • Medidata (MDSO) Up 2.3% Since Last Earnings Report: Can It Continue?
    Zacks2 months ago

    Medidata (MDSO) Up 2.3% Since Last Earnings Report: Can It Continue?

    Medidata (MDSO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Medidata's Cloud Platform Picked by China's Hengrui, Stock Up
    Zacks2 months ago

    Medidata's Cloud Platform Picked by China's Hengrui, Stock Up

    Medidata's (MDSO) cloud-based platform sees immense prospects in APAC.